Literature DB >> 1888631

The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.

M D Tingle1, M D Coleman, B K Park.   

Abstract

We have examined the ability of cimetidine to inhibit the oxidative metabolism and hence haemotoxicity of dapsone in vitro, using a two compartment system in which two Teflon chambers are separated by a semi-permeable membrane. Compartment A contained a drug metabolizing system (microsomes prepared from human or rat liver +/- NADPH), whilst compartment B contained human red cells. Preincubation (30 min) of human liver microsomes with cimetidine (0-1000 microM) and NADPH prior to the addition of dapsone (100 microM) and NADPH (1 mM) resulted in a concentration-dependent decrease in the concentrations of dapsone hydroxylamine (from 179 +/- 47 to 40 +/- 6 ng) in compartment B. This reduction of hydroxylamine metabolite was reflected in the concentration-dependent reduction in methaemoglobin measured (from 7.1 +/- 0.7 to 3.5 +/- 1.5%) in parallel experiments. Preincubation of microsomes with cimetidine in the absence of NADPH had no effect. The effect of cimetidine pretreatment on dapsone-dependent methaemoglobin was confirmed using microsomes prepared from a further three sources of human liver, as well as from rat liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888631      PMCID: PMC1368503          DOI: 10.1111/j.1365-2125.1991.tb05623.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Inhibition of dapsone-induced methaemoglobinaemia in the rat.

Authors:  M D Coleman; M J Winn; A M Breckenridge; B K Park
Journal:  Biochem Pharmacol       Date:  1990-02-15       Impact factor: 5.858

2.  Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites.

Authors:  Z H Israili; S A Cucinell; J Vaught; E Davis; J M Lesser; P G Dayton
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

3.  Microsomal N-oxidation of dapson as a cause of methemoglobin formation in human red cells.

Authors:  S A Cucinell; Z H Israili; P G Dayton
Journal:  Am J Trop Med Hyg       Date:  1972-05       Impact factor: 2.345

4.  Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolism.

Authors:  M J Serlin; M Challiner; B K Park; P A Turcan; A M Breckenridge
Journal:  Biochem Pharmacol       Date:  1980-07-01       Impact factor: 5.858

Review 5.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

6.  Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.

Authors:  M W Teunissen; C H Kleinbloesem; L G de Leede; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 7.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

8.  Role of aniline metabolites in aniline-induced hemolytic anemia.

Authors:  J H Harrison; D J Jollow
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

9.  Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.

Authors:  J C Jensen; R Gugler
Journal:  Biochem Pharmacol       Date:  1985-06-15       Impact factor: 5.858

10.  The effects of cimetidine on the oxidative metabolism of estradiol.

Authors:  R A Galbraith; J J Michnovicz
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

View more
  5 in total

Review 1.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.

Authors:  H J Gill; M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

3.  The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.

Authors:  V Spaldin; S Madden; W F Pool; T F Woolf; B K Park
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

4.  The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 5.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.